Heart Health
Cardiovascular disease begins before the heart attack.
Your cardiovascular system is always moving. With every heartbeat, blood travels through thousands of miles of vessels, delivering oxygen and nutrients while carrying away carbon dioxide and waste. When the system is healthy the heart pumps efficiently, blood vessels expand and contract, blood pressure stays appropriately regulated, and the inner lining of the arteries helps control inflammation, clotting, circulation and vessel tone. Those functions can begin changing years before anyone experiences chest pain, a stroke or heart failure.
Begin reading
The quiet years
What changes before anything is felt
Where it actually begins
The blood vessels
Blood pressure
Metabolism
Daily conditions
The heart is where it becomes visible. It is rarely where the story started.
Heart disease may become visible at the heart. But the process often begins earlier, in the blood vessels, in metabolism, in blood pressure and in the daily conditions surrounding them. By the time an event announces itself, the biology behind it has usually been under way for a long time.
That is not a reason for alarm. It is the reason prevention works at all, and it is why a cardiovascular evaluation looks at more than one number.
This page explains the system, what can be measured, what the measurements mean and when symptoms need emergency care.
The central idea
The cardiovascular event is often the final chapter of a story that began years earlier.
Which means the useful work happens in the chapters before it.
Free guide
Get Beyond Cholesterol
A basic cholesterol panel is useful. It is not the complete cardiovascular story. The free guide explains how lipoproteins, blood pressure, blood sugar, inflammation, family history, lifestyle and selected imaging can be read together.
Beyond Cholesterol
What a standard panel misses about cardiovascular risk.
More than the heart
The heart is the pump. The vessels are the living network.
The heart moves the blood. The blood vessels are the delivery network, and the blood itself carries oxygen, nutrients, hormones, immune cells, lipoproteins and countless signalling molecules to every tissue in the body. Different cardiovascular conditions involve different parts of that network, which is why they are not interchangeable and why treatment has to match the part involved.
The cardiovascular system
The pump
The network
Blood pressure regulation and the clotting and anticoagulation systems run across all of it.
Coronary artery disease affects blood flow to the heart. Stroke involves blood flow within the brain. Peripheral artery disease affects circulation to the limbs. Heart failure affects the heart’s ability to meet the body’s circulatory needs. Arrhythmias involve the electrical rhythm. Valve disease affects how blood moves through the chambers. These conditions share risk factors. They are not the same problem.
The vessel lining
The inner surface of every blood vessel is alive.
The inside of a blood vessel is not passive plumbing. It is lined by a thin layer of cells called the endothelium, and that lining helps regulate vessel dilation, blood pressure, clotting, inflammation, the movement of substances through the vessel wall, oxidative balance and repair after injury.
A healthy endothelium helps the artery stay responsive and resistant to unnecessary clotting and inflammation. When it becomes dysfunctional the vessel may dilate less readily, become more permeable, become more inflammatory and become more vulnerable to atherosclerosis.
That does not make endothelial dysfunction the single cause of cardiovascular disease. It is one important biological environment in which many recognised risk factors converge.
Cardiovascular risk is not only about what circulates in the blood. It is also about the condition of the vessels carrying it.
Healthy and dysfunctional
Same vessel
Responsive
Dysfunctional
What actually happens
Atherosclerosis is a process in the wall, not sludge in a pipe.
Atherosclerosis is the progressive build up of plaque within the walls of arteries. It involves considerably more than cholesterol sticking to the inside of a tube. Lipoprotein particles enter the arterial wall. Some become retained and modified. Immune cells respond. Inflammation develops. A plaque begins to form. What happens next is not the same for every plaque.
The sequence
What may happen next
Remain relatively stable
Become calcified
Narrow the artery
Become vulnerable
A plaque does not need to block an artery completely before it becomes dangerous. If a vulnerable plaque ruptures, a clot may form and interrupt blood flow abruptly.
In a coronary artery that can cause a heart attack. In an artery supplying the brain it can contribute to an ischaemic stroke. So the central cardiovascular question is not simply what is my cholesterol. It is what is my overall likelihood of developing, or already having, vascular disease.
Necessary and consequential
Cholesterol is essential. Particle exposure still matters.
Cholesterol performs essential work. The body uses it to help build cell membranes, steroid hormones, bile acids, vitamin D and nervous system structures. Because it does not dissolve freely in blood, it travels inside lipoprotein particles. Low density lipoproteins carry cholesterol and other lipids from the liver into circulation. High density lipoproteins participate in cholesterol transport and several other biological functions.
How it travels
Cholesterol does not float loose in blood. It is carried inside particles.
The concern is not that cholesterol exists. It is that greater lifetime exposure to atherogenic particles increases the opportunity for them to enter and remain in vulnerable walls.
What an evaluation weighs
No single result should be read in isolation.
Cholesterol is biologically necessary. Atherogenic particle exposure is still clinically meaningful. Both statements can be true.
For a longer discussion of what cholesterol does and how the sub-fractions differ, see Cholesterol: Friend or Foe?
Two different questions
LDL cholesterol and ApoB do not measure the same thing.
LDL cholesterol estimates how much cholesterol is being carried within LDL particles. Apolipoprotein B helps estimate how many atherogenic particles are present, since each of those particles carries one ApoB molecule.
Two people can have similar LDL cholesterol and different particle numbers. That gap matters most when triglycerides, insulin resistance, diabetes or metabolic syndrome change the relationship between the amount of cholesterol and the number of particles carrying it.
Neither marker makes the rest of the evaluation unnecessary. They add different pieces of information to the same picture.
Same cholesterol, different particles
Two people
Person A
Fewer, larger particles
Lower ApoB
Person B
More, smaller particles
Higher ApoB
Similar LDL cholesterol. Different particle burden. Context decides whether the two measures agree.
Largely inherited
Lipoprotein(a) does not show up on a standard panel.
Lipoprotein(a), usually written Lp(a), is an inherited lipoprotein that can contribute to atherosclerotic and valvular cardiovascular risk. Levels are strongly influenced by genetics and are not reliably predicted by a standard cholesterol panel. Someone can have an otherwise unremarkable lipid profile while carrying elevated Lp(a). Because levels are generally stable across adult life, a single measurement usually answers the question.
An elevated result does not mean disease will develop. It changes where the person sits in the overall risk picture, and it should be interpreted with their complete profile rather than on its own.
Continuous physical stress
Blood pressure does not need to hurt before it causes harm.
Blood pressure is the force exerted against arterial walls as the heart pumps and relaxes. When pressure stays elevated, the vessel wall experiences repeated mechanical stress, and that stress is felt in more than one organ. High blood pressure usually produces no obvious symptoms at all, which is precisely why measurement matters.
Sustained pressure
Repeated mechanical stress on the vessel wall.
Where it is felt
One elevated reading does not establish chronic hypertension. Repeated measurements, proper technique, home readings and clinical context decide whether the pattern is persistent.
Metabolic and vascular
Blood sugar is also a cardiovascular signal.
Blood sugar disorders are not confined to diabetes. Insulin resistance, elevated glucose and diabetes all influence the blood vessels, the kidneys, the nervous system, the liver and lipoprotein metabolism. This is one of the clearest reasons a cardiovascular evaluation should include more than cholesterol.
How the chain runs
The downstream changes
Endothelial dysfunction
Oxidative stress
Inflammation
Elevated triglycerides
Changes in lipoprotein composition
High blood pressure
Kidney disease
Increased clotting risk
Useful markers may include fasting glucose, HbA1c, fasting insulin, triglycerides, waist circumference, blood pressure, liver markers and kidney function.
Heart health and metabolic health are deeply connected. Blood Sugar and Metabolic Health covers this side of the picture in full.
One contributor, not the verdict
Inflammation belongs in the story. It is not the whole story.
Atherosclerosis involves inflammatory activity within the arterial wall. That does not mean a single inflammatory marker can diagnose cardiovascular disease. C-reactive protein may add risk information in selected patients, but it is nonspecific and can rise because of infection, injury, autoimmune disease, obesity or other inflammatory conditions entirely unrelated to the arteries.
The useful question is not do I have inflammation. It is whether inflammation meaningfully changes how my cardiovascular risk should be understood or managed.
Vascular response
Nitric oxide helps blood vessels respond.
Nitric oxide is one of several molecules that help blood vessels relax and regulate circulation. Healthy endothelial cells produce it in response to chemical signals and to the movement of blood across the vessel wall, which supports vasodilation, blood pressure regulation, tissue perfusion, exercise responses, vascular repair and reduced platelet activation.
Its biology can be influenced by physical activity, blood pressure, blood sugar, smoking, oxidative stress, ageing, vascular disease and dietary patterns.
Nitric oxide is important. It is not a stand alone diagnosis, not a substitute for cardiovascular risk assessment, and not a reason to build treatment around one supplement. The larger objective is to maintain vessels capable of responding appropriately.
How a vessel answers demand
Response
Healthy response
Flow increases, the lining signals, the vessel widens.
Reduced response
Less dilation, greater stiffness, less perfusion.
Nitric oxide supports vasodilation, pressure regulation, perfusion, exercise response and repair. It is not a diagnosis on its own.
Not the same problem
The heart and the blood vessels require different evaluation.
A person can have a structurally normal heart with significant vascular disease. Another can have serious heart disease without atherosclerosis. Lifestyle and metabolic care matter across many of these conditions, and they do not replace cardiology evaluation, imaging, rhythm monitoring, medication, procedures or surgery when those are needed.
The arteries themselves
Coronary artery disease, carotid artery disease, peripheral artery disease, aortic disease, cerebrovascular disease and venous thromboembolism.
The pump itself
Cardiomyopathy, heart failure and myocarditis. The muscle may weaken, stiffen or become inflamed without any plaque being involved.
Rhythm and timing
Atrial fibrillation, supraventricular tachycardia, ventricular arrhythmias and bradyarrhythmias. These are problems of signalling, not supply.
Flow through the chambers
Aortic stenosis, mitral regurgitation, valve prolapse and congenital valve abnormalities. Structure rather than circulation.
Different parts of the cardiovascular system require different forms of evaluation and treatment.
Two different starting points
Cardiovascular disease can be silent.
Some people experience warning symptoms. Others do not know disease is present until a significant event occurs. Those two situations call for different responses, and the absence of symptoms is not the same as the absence of disease.
Where warning symptoms are present, the priority is evaluation matched to the severity and speed of those symptoms. Where there are none, the work is risk assessment and prevention built from history, measurements, laboratory testing and, when it is justified, selected imaging.
The symptom patterns below are worth recognising. They require appropriate medical evaluation. They should not be diagnosed from a website.
Patterns by territory
Recognising
Coronary
Chest pressure or tightness
Shortness of breath
Pain to arm, jaw, back or upper abdomen
Nausea, sweating, unusual fatigue
Cerebrovascular
Sudden facial or limb weakness
Numbness on one side
Difficulty speaking or understanding
Sudden visual change or loss of balance
Peripheral and heart failure
Leg discomfort with walking
Coldness, weak pulses, slow healing wounds
Swelling of the legs, rapid fluid weight gain
Breathlessness lying flat or waking at night
A vascular clue
Erectile dysfunction can be an early circulation signal.
Erectile function depends in part on healthy blood flow and vascular responsiveness. In some men, erectile dysfunction appears before coronary symptoms, because the penile arteries are smaller than the coronary arteries and a given degree of vascular change shows up there sooner.
The starting point
Family history changes where the assessment begins.
Family history can raise cardiovascular concern even when current symptoms are absent. It does not guarantee the same outcome. What it changes is the threshold for evaluation, the timing of screening and how assertively risk factors are managed.
Patterns that matter
Heart attack or stroke at a young age
Familial hypercholesterolemia
Very high LDL cholesterol
Elevated Lp(a)
Sudden unexplained death
Cardiomyopathy
Aortic disease
Inherited arrhythmia syndromes
Multiple affected close relatives
Genes may influence lipoproteins, blood pressure, clotting, heart structure, electrical rhythm and how the body responds to environmental conditions.
Owning your biology includes knowing the cardiovascular story you inherited.
Pattern over nutrient
There is no single perfect heart diet.
The strongest dietary patterns tend to share a set of features rather than a set of rules. Minimally processed foods, vegetables and fruit, legumes, nuts and seeds, adequate fibre, unsaturated fats, fish where appropriate, limited trans fat, limited excess sodium, limited refined carbohydrate, limited ultra processed food, and energy intake matched to the person.
What a meal can influence
Blood sugar
Triglycerides
Blood pressure
Satiety
Body composition
The microbiome
Inflammation
Lipoprotein metabolism
Diet should be adapted to metabolic health, kidney function, medications, blood pressure, food access, preference and culture.
The best cardiovascular diet is not the one with the most rules. It is the one that consistently improves the person’s risk profile and can be sustained.
Replacement matters
Saturated fat requires context.
Saturated fat can raise LDL cholesterol in many people, although the size of that response varies considerably between individuals. The health effect of changing intake depends partly on what replaces it, and a dietary pattern rich in vegetables, legumes, nuts, fish and minimally processed foods should not be judged by one isolated nutrient.
The practical questions are what the person is eating now, what will replace the saturated fat, how their LDL, ApoB, triglycerides, blood sugar and blood pressure respond, and whether the change is sustainable. For the longer discussion see Bad Fats or Facts? Saturated Fat and the Diet Heart Hypothesis.
Trainable
Movement trains the vascular system.
Exercise is one of the most direct ways to challenge and strengthen cardiovascular function. Regular movement supports blood pressure regulation, insulin sensitivity, glucose control, lipoprotein metabolism, endothelial function, cardiorespiratory fitness, muscle mass, stress regulation, sleep and long term independence. Cardiorespiratory fitness is itself an important health indicator.
The right dose depends on current conditioning, existing cardiovascular disease, symptoms, blood pressure, joint and neurological limitations, medication, recovery capacity and medical clearance where that is appropriate. The goal is not maximal intensity for everyone. It is progressive, sustainable capacity.
Overnight and ongoing
Sleep and stress reach the cardiovascular system.
Sleep regulates more than alertness. Inadequate or disrupted sleep can influence blood pressure, appetite, blood sugar, sympathetic nervous system activity, inflammation, recovery, food choices and exercise capacity.
Sleep apnoea deserves particular attention, because repeated interruptions in breathing can contribute to hypertension, rhythm disturbances, daytime fatigue and cardiovascular risk. It is common, frequently undiagnosed, and treatable.
Psychological stress affects blood pressure, sleep, behaviour, autonomic balance and medication adherence. Stress is not the sole cause of heart disease. But the body does not separate emotional experience from cardiovascular physiology.
What sleep touches
Overnight
What sleep influences
Blood pressure
Appetite
Blood sugar
Recovery
Sympathetic activity
Food choices
Inflammation
Exercise capacity
Sleep apnoea
Hypertension
Rhythm disturbance
Daytime fatigue
Common, often undiagnosed, and treatable.
Exposure
Smoking and air exposure matter.
Tobacco exposure can injure the vascular lining, increase clotting risk, accelerate atherosclerosis and reduce oxygen delivery. The cardiovascular effect is not limited to cigarettes. Nicotine products, secondhand smoke and other inhaled exposures may also matter, and air pollution contributes another environmental layer. The goal is not environmental perfection. It is exposure reduction where the evidence and the person’s history justify it.
Stopping tobacco use remains one of the highest value cardiovascular interventions available.
Where inhaled and environmental exposure is a larger part of the picture, Environmental Medicine covers how exposure and capacity are assessed.
Above the neck
Oral health belongs in the cardiovascular conversation.
The mouth is part of the body. Periodontal disease creates chronic local inflammation and has been associated with cardiovascular risk. Bleeding gums, persistent swelling, loose teeth, pain with chewing and chronic bad breath all deserve dental evaluation. Treating gum disease should not be advertised as a cure for atherosclerosis, and oral health is still a legitimate part of whole person cardiovascular care.
The heart health plan should not begin at the neck and ignore everything above it.
Five layers
What a cardiovascular evaluation can include.
Not every layer applies to every person. The layers exist so that testing follows the clinical question rather than the other way around.
Five layers
No one needs every cardiovascular test. The test should match the question.
What the foundational panel covers, and why reference ranges are not the same as optimal ranges, is set out in Comprehensive Blood Chemistry. For the fuller assessment discussion see How to Properly Assess for Cardiovascular and Heart Disease.
A refinement tool
What coronary calcium scoring can and cannot tell you.
A coronary artery calcium scan is a low dose CT test that detects calcified plaque within the coronary arteries. The result can help refine cardiovascular risk in selected adults when a treatment decision remains genuinely uncertain.
A score of zero can be reassuring in some contexts. It does not guarantee the absence of all plaque, and it does not eliminate risk from smoking, diabetes, strong family history, symptoms or other high risk conditions. A higher score indicates a greater burden of calcified coronary plaque.
It is a risk refinement tool. It is not a universal screening requirement for every person, and the result should be interpreted alongside age, symptoms, lipids, blood pressure, diabetes, smoking, family history and kidney function.
Risk and disease
Different questions
Estimated risk
History
Blood pressure
Laboratory markers
Family history
Risk calculation
Evidence of disease
Coronary calcium
CT angiography
Stress testing
Ankle brachial index
Echocardiography
Risk markers estimate probability. Imaging may reveal whether disease is already present.
Restraint
More testing is not always better testing.
Large cardiovascular panels can produce impressive reports without improving the decision. Every marker should answer a defined question, and six questions asked before ordering usually prevent a great deal of confusion afterwards.
The best cardiovascular assessment is not the one with the most biomarkers. It is the one that most clearly identifies risk and guides the next decision.
Both, in proportion
Medication and whole person care are not opponents.
Statins reduce cholesterol synthesis and lower circulating LDL cholesterol. For many patients, particularly those with established atherosclerotic cardiovascular disease or sufficiently elevated risk, they reduce the likelihood of future cardiovascular events. A functional approach should not begin with the assumption that statins are unnecessary, and it should not reduce cardiovascular health to medication alone.
Two kinds of risk reduction
Medical risk reduction
Lipid lowering therapy
Blood pressure treatment
Diabetes medication
Antiplatelet or anticoagulant therapy when indicated
Cardiology, procedures and cardiac rehabilitation
Daily risk reduction
Nutrition
Physical activity
Sleep
Smoking cessation
Metabolic health, stress and medication adherence
Where they overlap is comprehensive prevention. Do not stop or change prescribed cardiovascular medication without speaking to the prescribing clinician.
The goal is not to choose between medication and lifestyle. It is to use every appropriate tool in proportion to the person’s risk.
The decision depends on existing disease, overall estimated risk, LDL cholesterol, ApoB and Lp(a) where relevant, diabetes, family history, blood pressure, smoking status, imaging, age, preference and tolerance of medication. For a fuller treatment of how statins work and how to weigh the tradeoffs, see Statin Drugs: Are They Worth the Risks?
The sequence I use
How I evaluate cardiovascular risk.
This is a clinical sequence, not a self diagnosis tool. It exists to keep prevention, risk refinement and active disease from being confused with one another.
The more immediate the risk, the less appropriate it is to rely on slow lifestyle change alone.
Call emergency services
Some cardiovascular symptoms are an emergency.
These symptoms need emergency care, not an appointment and not a form. Do not drive yourself when a heart attack, stroke, pulmonary embolism or other cardiovascular emergency is possible. New symptoms should not be dismissed because a person is young, fit, or has previously had normal cholesterol.
Chest pressure, squeezing, fullness or pain
Sudden shortness of breath
Pain into the arm, shoulder, jaw, neck, back or upper abdomen
Sudden sweating with chest discomfort
Fainting
A new rapid or irregular heartbeat with weakness
Sudden facial drooping
One sided weakness or numbness
Sudden speech difficulty
Sudden vision loss
Sudden severe headache
Sudden loss of balance
Coughing blood with chest pain or breathlessness
A suddenly cold, pale, painful or numb limb
Free guide
Understand your risk before a number defines the story
What cholesterol does, how LDL cholesterol and ApoB differ, why blood pressure and blood sugar matter, when additional testing helps, what coronary calcium scoring can and cannot tell you, how medication and lifestyle work together, and which questions to bring to your clinician.
Return to the library
Explore all health conditions
Every condition guide, organised by system, each one written to explain the physiology before the protocol.
Own your biology
Heart health is not one number.
It is not simply cholesterol. It is not simply blood pressure. And it is not simply whether someone feels symptoms today. Cardiovascular health reflects the condition of the heart, the vessel wall, the blood moving through it and the metabolic environment surrounding the entire system.
Owning your biology here means keeping five pairs of things apart, because most of the confusion in cardiovascular care comes from collapsing one of them.
Cholesterol from lipoprotein risk The molecule is essential. The particle burden is what accumulates in a wall over a lifetime.
Risk markers from existing disease One estimates probability. The other reports what is already there.
Prevention from emergency care Slow change is the right answer for one and the wrong answer for the other.
Lifestyle support from necessary medication They are not competitors, and the proportion should follow the risk.
One elevated result from the complete pattern A single number rarely decides anything on its own.
Bring the whole picture, not just the panel.
No pressure, and nothing to buy. Bring your lipid results, your blood pressure readings, any imaging you have had, your family history, what you are taking and what has already been tried, and we can work out together what your numbers actually mean and what belongs in the next decision.
Common questions
Questions about heart health.
Short, plain answers to what people ask most about cholesterol, statins, calcium scoring and prevention.
Is high cholesterol always bad?
What is the difference between LDL cholesterol and ApoB?
Should everyone get a coronary calcium scan?
Can atherosclerosis be reversed?
Does saturated fat cause heart disease?
My cholesterol is normal. Can I still have heart disease?
Should I stop my statin and try lifestyle instead?
What tests assess heart disease risk beyond cholesterol?
References
Sources behind this page
These are the sources consulted in writing this guide. They include work that disagrees with itself on how strongly lipoproteins drive risk, which is an accurate reflection of the literature rather than an oversight.
- Alizadeh-Fanalou, S., Nazarizadeh, A., Alian, F., et al. (2020). Small dense low-density lipoprotein-lowering agents. Biological Chemistry, 401(10), 1101-1121. https://doi.org/10.1515/hsz-2019-0426
- Alphonse, P. A. S., & Jones, P. J. H. (2016). Revisiting human cholesterol synthesis and absorption. Lipids, 51(5), 519-536. https://doi.org/10.1007/s11745-015-4096-7
- Blesso, C. N., & Fernandez, M. L. (2018). Dietary cholesterol, serum lipids, and heart disease: Are eggs working for or against you? Nutrients, 10(4), 426. https://doi.org/10.3390/nu10040426
- Fernández-Friera, L., Fuster, V., López-Melgar, B., et al. (2017). Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. Journal of the American College of Cardiology, 70(24), 2979-2991. https://doi.org/10.1016/j.jacc.2017.10.024
- Ference, B. A., Kastelein, J. J. P., & Catapano, A. L. (2020). Lipids and lipoproteins in 2020. JAMA, 324(6), 595. https://doi.org/10.1001/jama.2020.5685
- Goldstein, J. L., & Brown, M. S. (2015). A century of cholesterol and coronaries: From plaques to genes to statins. Cell, 161(1), 161-172. https://doi.org/10.1016/j.cell.2015.01.036
- Greenland, P., Blaha, M. J., Budoff, M. J., Erbel, R., & Watson, K. E. (2018). Coronary calcium score and cardiovascular risk. Journal of the American College of Cardiology, 72(4), 434-447. https://doi.org/10.1016/j.jacc.2018.05.027
- Hooper, L., Martin, N., Abdelhamid, A., & Davey Smith, G. (2015). Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011737
- Jensen, M. K., Bertoia, M. L., Cahill, L. E., et al. (2014). Novel metabolic biomarkers of cardiovascular disease. Nature Reviews Endocrinology, 10(11), 659-672. https://doi.org/10.1038/nrendo.2014.155
- Libby, P., Buring, J. E., Badimon, L., et al. (2019). Atherosclerosis. Nature Reviews Disease Primers, 5(1), 56. https://doi.org/10.1038/s41572-019-0106-z
- Parsons, C., Agasthi, P., Mookadam, F., & Arsanjani, R. (2018). Reversal of coronary atherosclerosis: Role of lifestyle and medical management. Trends in Cardiovascular Medicine, 28(8), 524-531. https://doi.org/10.1016/j.tcm.2018.05.002
- Ravnskov, U., de Lorgeril, M., Diamond, D. M., et al. (2018). LDL-C does not cause cardiovascular disease: A comprehensive review of the current literature. Expert Review of Clinical Pharmacology, 11(10), 959-970. https://doi.org/10.1080/17512433.2018.1519391
- Sachdeva, A., Cannon, C. P., Deedwania, P. C., et al. (2009). Lipid levels in patients hospitalized with coronary artery disease. American Heart Journal, 157(1), 111-117.e2. https://doi.org/10.1016/j.ahj.2008.08.010
- Vernooij, R. W. M., Zeraatkar, D., Han, M. A., et al. (2019). Patterns of red and processed meat consumption and risk for cardiometabolic and cancer outcomes. Annals of Internal Medicine, 171(10), 732-741. https://doi.org/10.7326/M19-1583
